Home » Stocks » LHDX

Lucira Health, Inc. (LHDX)

Stock Price: $5.63 USD 0.32 (6.03%)
Updated Jun 11, 2021 4:00 PM EDT - Market closed
After-hours: $5.66 +0.03 (0.53%) Jun 11, 7:59 PM
Market Cap 217.17M
Revenue (ttm) 4.79M
Net Income (ttm) n/a
Shares Out 22.89M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day June 11
Last Price $5.63
Previous Close $5.31
Change ($) 0.32
Change (%) 6.03%
Day's Open 5.80
Day's Range 5.41 - 5.88
Day's Volume 693,982
52-Week Range 4.23 - 37.99

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

EMERYVILLE, Calif.--(BUSINESS WIRE)--Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease...

2 weeks ago - Business Wire

This start-up's over-the-counter COVID-19 tests could be a huge hit.

2 weeks ago - The Motley Fool

EMERYVILLE, Calif, May 13, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health," "Lucira" or the "Company") (NASDAQ: LHDX), a medical technology company focused on the development and commercia...

1 month ago - GlobeNewsWire

Second Sight Medical Products, Inc. (NASDAQ: EYES), Lucira Health, Inc. (NASDAQ: LHDX) and Ra Medical Systems, Inc. (NYSE: RMED) were among the biggest health care gainers Wednesday. Second Sight Rallie...

Other stocks mentioned: EYES, RMED
1 month ago - Benzinga

EMERYVILLE, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”) (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of tr...

1 month ago - GlobeNewsWire

This coronavirus testing stock has taken shareholders on a roller-coaster ride since its IPO.

1 month ago - The Motley Fool

EMERYVILLE, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”) (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of ...

1 month ago - GlobeNewsWire

EMERYVILLE, Calif.--(BUSINESS WIRE)--Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease...

Other stocks mentioned: JBL
1 month ago - Business Wire

EMERYVILLE, Calif.--(BUSINESS WIRE)--Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease...

1 month ago - Business Wire

EMERYVILLE, Calif.--(BUSINESS WIRE)--Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease...

1 month ago - Business Wire

This analyst thinks the company's stock performance will trail that of the market.

2 months ago - The Motley Fool

The company's COVID-19 Test Kit will soon be available for sale at a pharmacy near you.

2 months ago - The Motley Fool

EMERYVILLE, Calif.--(BUSINESS WIRE)--Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease...

2 months ago - Business Wire

After the sell-off in February, the markets have sprung back up. The broader S&P 500 Index is trading at an all-time high and the blue-chip Dow Jones Industrial Index is just shy of its all-time peak.

Other stocks mentioned: PRDO, VERX
2 months ago - Benzinga

EMERYVILLE, Calif.--(BUSINESS WIRE)--Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease...

2 months ago - Business Wire

EMERYVILLE, Calif.--(BUSINESS WIRE)--Lucira Health, Inc. (Nasdaq: LHDX), today announced that U.S. physicians and healthcare providers can now order Lucira COVID-19 All-In-One Test Kits online from luci...

4 months ago - Business Wire

EMERYVILLE, Calif.--(BUSINESS WIRE)--Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of transformative and innovative inf...

4 months ago - Business Wire

EMERYVILLE, Calif.--(BUSINESS WIRE)--Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of transformative and innovative inf...

4 months ago - Business Wire

Lucira Health, which is developing single-use test kits for COVID-19 and other infectious diseases, filed on Friday with the SEC to raise up to $115 million in an initial public offering.

4 months ago - NASDAQ

Lucira Health, Inc. has filed to go public with an IPO on the NASDAQ.

4 months ago - SEC

Amid surging coronavirus cases, the top U.S. testing official on Thursday announced another scale-up in the country’s diagnostic efforts, touting the importance of tests that can run from start to finis...

5 months ago - The New York Times

About LHDX

Lucira Health is a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits. We have developed a testing platform that produces centralized-laboratory-accurate molecular testing in a single-use and consumer-friendly test kit that is powered by two AA batteries and fits in the palm of a hand. We designed our test kits to provide accurate, reliable and on-the-spot molecular test results anywhere and at any time. Our LUCIRA COVID-19 All-In-One Test Kit, or our COVID-1... [Read more...]

Industry
Diagnostics & Research
IPO Date
Feb 5, 2021
CEO
Erik T. Engelson
Employees
71
Stock Exchange
NASDAQ
Ticker Symbol
LHDX
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

The average 12-month stock price forecast for Lucira Health is 8.50, which is an increase of 50.98% from the latest price.

Price Target
$8.50
(50.98% upside)